Hormone receptor-positive (HR+) and human epidermal growth factor receptor 2 negative (HER2−) breast cancer are the most common subtypes, accounting for approximately 70% of all breast cancer cases in the United States. This evidence concerns the gene ERBB2 and breast carcinoma.